| Name | Title | Contact Details |
|---|---|---|
Alfred Intintoli |
Chief Technology Officer | Profile |
Fairway Medical Technologies is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HealthCube ensures that accurate diagnosis is within easy and convenient reach of billions of people in both developed and developing economies. HealthCube designs and manufactures point-of-care diagnostic devices to enhance the quality of primary care in diverse settings. HealthCube`s multiparametric technology can test for over 30 parameters including blood glucose, hemoglobin, blood pressure, detect infectious diseases markers, and even perform ECGs. Their easy-to-use and portable devices are medical grade, clinically validated, and digitally enabled, with results available instantly. HealthCube is an ISO 13485 certified company which has received certification from Central Drugs Standard Control Organization (CDSCO) and European CE. HealthCube is backed by global marquee investors including Alkemi Ventures, Perot-Jain Ventures, Acumen, and SV Latam Capital. As of date, over one million beneficiaries have been registered on HealthCube Ecosystem and 2.5 million tests have been performed.
Transgenomic is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. The Company is the global leader in cardiac genetic testing with a family of innovative products designed to detect gene mutations which indicate cardiac disorders, or which can lead to serious adverse events. Transgenomic has three complementary business divisions: Transgenomic Clinical Laboratories, which specializes in molecular diagnostics for cardiology, oncology, neurology, and mitochondrial disorders; Transgenomic Pharmacogenomic Services, a contract research laboratory that specializes in supporting all phases of pre-clinical and clinical trials for oncology drugs in development; and Transgenomic Diagnostic Tools, which produces equipment, reagents, and other consumables that empower clinical and research applications in molecular testing and cytogenetics. Transgenomic believes there is significant opportunity for continued growth across all three businesses by leveraging their synergistic capabilities, technologies, and expertise. The Company actively develops and acquires new technology and other intellectual property that strengthens its leadership in personalized medicine.
Volpara Health Technologies Limited is a leading provider of breast imaging analytics and analysis products that improve clinical decision-making and the early detection of breast cancer. Every day, Volpara software helps clinicians better understand their patients and administrators better understand their practices. Volpara Health Technologies Limited (formerly Matakina Technology Limited) is a research, development, and manufacturing company based in Wellington, New Zealand. With a diverse research team led by internationally recognized experts in medical physics, as well as proprietary medical imaging technology covered by multiple patents and trademarks, we apply science to the solving of clinical problems around the world. Volpara Health Technologies Limited holds certification to ISO13485 and is a US FDA–registered establishment whose products are listed accordingly. In addition, our products hold CE Marking under European Medical Device Directive 93/42/EEC. Volpara Solutions Limited is our wholly owned sales and marketing subsidiary.
XinVivo – a UNC spin-out founded in 2015 and based off Airport Boulevard in Morrisville. The company specializes in developing and manufacturing 3D imaging systems. Specifically, the company is developing carbine nanotube X-ray source array technology, which it claims increases speed while reducing radiation and costs.